Evidence map›Paper›PMID 23451120›Full record

ArticlePloS one2013

A cis-acting element present within the Gag open reading frame negatively impacts on the activity of the HIV-1 IRES.

Fernando Valiente-Echeverría, Maricarmen Vallejos, Anne Monette, Karla Pino, Alejandro Letelier, J Pablo Huidobro-Toro, Andrew J Mouland, Marcelo López-Lastra

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. HIV Rev-isited.Open biology · 2020
    Review
  4. Article
  5. Focus on Translation Initiation of the HIV-1 mRNAs.International journal of molecular sciences · 2018
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Translation initiation of the HIV-1 mRNA.Translation (Austin, Tex.) · 2014
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Fernando Valiente-EcheverríaLaboratorio de Virología Molecular, Instituto Milenio de Inmunología e Inmunoterapia, Centro de Investigaciones Médicas, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Maricarmen Vallejos
Anne Monette
Karla Pino
Alejandro Letelier
J Pablo Huidobro-Toro
Andrew J Mouland
Marcelo López-Lastra
Pontificia Universidad Católica de Chile · CLMcGill University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Translation initiation from the human immunodeficiency virus type-1 (HIV-1) mRNA can occur through a cap or an IRES dependent mechanism. Cap-dependent translation initiation of the HIV-1 mRNA can be inhibited by the instability element (INS)-1, a cis-acting regulatory element present within the gag open reading frame (ORF). In this study we evaluated the impact of the INS-1 on HIV-1 IRES-mediated translation initiation. Using heterologous bicistronic mRNAs, we show that the INS-1 negatively impact on HIV-1 IRES-driven translation in in vitro and in cell-based experiments. Additionally, our results show that the inhibitory effect of the INS-1 is not general to all IRESes since it does not hinder translation driven by the HCV IRES. The inhibition by the INS-1 was partially rescued in cells by the overexpression of the viral Rev protein or hnRNPA1.

Indexed as

Genes, gagHeLa CellsHIV-1HumansImmunoblottingOpen Reading FramesRegulatory Sequences, Nucleic AcidReverse Transcriptase Polymerase Chain Reactionrev Gene Products, Human Immunodeficiency Virusrev Gene Products, Human Immunodeficiency Virus

Identifiers

PMID23451120
PMCPMC3581557
OpenAlexW2034442061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.